Patents by Inventor John Ernest Hart

John Ernest Hart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8367801
    Abstract: A purified novel peptide micrin and its fragments are disclosed. The molecule has hormonal functions and has wide-ranging biological effects. Several uses are disclosed including its therapeutic potential in tissue reduction, tumour suppression, infertility and senescence. A micrin-recognising antibody and the micrin gene are also disclosed.
    Type: Grant
    Filed: January 12, 2009
    Date of Patent: February 5, 2013
    Assignee: Endocrine Pharmaceuticals Limited
    Inventor: John Ernest Hart
  • Publication number: 20100292438
    Abstract: A purified novel peptide micrin and its fragments are disclosed. The molecule has hormonal functions and has wide-ranging biological effects. Several uses are disclosed including its therapeutic potential in tissue reduction, tumour suppression, infertility and senescence. A micrin-recognising antibody and the micrin gene are also disclosed.
    Type: Application
    Filed: January 12, 2009
    Publication date: November 18, 2010
    Applicant: ENDOCRINE PHARMACEUTICALS LIMITED
    Inventor: John Ernest Hart
  • Patent number: 7700132
    Abstract: An endogenous mammalian material has been found which has the biological effect of causing a reduction in the mass of mammalian organs including the heart and prostate. The material has physico-chemical properties such that it appears as a compound of molecular weight between 10 and 20 kD when subjected to a purification process using membrane filtration followed by gel filtration. This material has therapeutic uses including the treatment of organ or tissue hypertrophy and hyperplasia.
    Type: Grant
    Filed: June 30, 2005
    Date of Patent: April 20, 2010
    Assignee: Endocrine Pharmaceuticals Limited
    Inventor: John Ernest Hart
  • Patent number: 7572465
    Abstract: A material having the ability to reduce organ mass has been isolated by collecting ovarian venous blood from a female mammal; preparing ovarian venous plasma from the blood; and at least partially purifying said material from the plasma. This material has therapeutic and other uses, e.g. in the treatment of organ or tissue hypertrophy.
    Type: Grant
    Filed: December 1, 1999
    Date of Patent: August 11, 2009
    Assignee: Endocrine Pharmaceuticals Limited
    Inventor: John Ernest Hart
  • Publication number: 20030158123
    Abstract: A method of purifying a material (“Micrin”) with the ability to reduce cell, tissue and organ size, mass and growth, comprises collection of ovarian follicular fluid from a mammal and at least partially purifying said material. Another method for purifying Micrin comprises collection of blood from a mammal and at least partially purifying said material, wherein during the collection a chelating agent is mixed with the collecting blood. Micrin or Micrin blockade has utility in the treatment of hyperplastic disorders, e.g. cancer, and also for preventing and treating a tissue-deficit disorder, or for controlling the shape, appearance or density of cells and tissues.
    Type: Application
    Filed: April 7, 2003
    Publication date: August 21, 2003
    Inventor: John Ernest Hart